In an attempt to further clarify the mechanism underlying the benefit of insulin in AD, Kellar et al. conducted a study in 2021 examining the effect of intranasal insulin on white matter health, cognition, and CSF biomarkers in adults with MCI or AD [82]. This evidence concerns the gene INS and Alzheimer disease.